Allscripts Healthcare Solutions Inc
NASDAQ:MDRX
Allscripts Healthcare Solutions Inc
Research & Development
Allscripts Healthcare Solutions Inc
Research & Development Peer Comparison
Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors
Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Allscripts Healthcare Solutions Inc
NASDAQ:MDRX
|
Research & Development
-$117.6m
|
CAGR 3-Years
22%
|
CAGR 5-Years
8%
|
CAGR 10-Years
2%
|
|
Veeva Systems Inc
NYSE:VEEV
|
Research & Development
-$629m
|
CAGR 3-Years
-29%
|
CAGR 5-Years
-32%
|
CAGR 10-Years
-37%
|
|
Inspire Medical Systems Inc
NYSE:INSP
|
Research & Development
-$119.8m
|
CAGR 3-Years
-61%
|
CAGR 5-Years
-71%
|
CAGR 10-Years
N/A
|
|
Evolent Health Inc
NYSE:EVH
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Doximity Inc
NYSE:DOCS
|
Research & Development
-$82m
|
CAGR 3-Years
-23%
|
CAGR 5-Years
-24%
|
CAGR 10-Years
N/A
|
|
Goodrx Holdings Inc
NASDAQ:GDRX
|
Research & Development
-$135.8m
|
CAGR 3-Years
-30%
|
CAGR 5-Years
-25%
|
CAGR 10-Years
N/A
|
See Also
What is Allscripts Healthcare Solutions Inc's Research & Development?
Research & Development
-117.6m
USD
Based on the financial report for Sep 30, 2022, Allscripts Healthcare Solutions Inc's Research & Development amounts to -117.6m USD.
What is Allscripts Healthcare Solutions Inc's Research & Development growth rate?
Research & Development CAGR 10Y
2%
Over the last year, the Research & Development growth was -7%. The average annual Research & Development growth rates for Allscripts Healthcare Solutions Inc have been 22% over the past three years , 8% over the past five years , and 2% over the past ten years .